We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$579M
AUM Growth
+$10.3M
Cap. Flow
+$40.5M
Cap. Flow %
7%
Top 10 Hldgs %
80.36%
Holding
86
New
13
Increased
9
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
2
COCH icon
Envoy Medical
COCH
+$4.26M
3
ROC
Rank One Computing Corp
ROC
+$3.19M
4
CRIS icon
Curis
CRIS
+$2.48M
5
VENU
Venu Holding Corp
VENU
+$2.31M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.13M
2
OWLT icon
Owlet
OWLT
+$1.46M
3
RHLD
Resolute Holdings Management
RHLD
+$1.04M
4
GPCR icon
Structure Therapeutics
GPCR
+$696K
5
LWLG icon
Lightwave Logic
LWLG
+$538K

Sector Composition

Rank Sector Weight
1 Industrials 23.83%
2 Healthcare 13.54%
3 Materials 5.99%
4 Technology 5.56%
5 Financials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TV icon
26
Televisa
TV
$1.49B
$3M 0.52%
1,030,000
– –
KZIA
27
Kazia Therapeutics
KZIA
$146M
$2.98M 0.51%
400,000
– –
QQQ icon
28
Invesco QQQ Trust
QQQ
$487B
$2.68M 0.46%
4,640
– –
DMAC icon
29
DiaMedica Therapeutics
DMAC
$369M
$2.59M 0.45%
382,317
– –
CRIS icon
30
Curis
CRIS
$3.91M
$2.08M 0.36%
190,116
+133,333
+235% +$2.48M
VENU
31
Venu Holding Corp
VENU
$116M
$1.99M 0.34%
600,000
+400,000
+200% +$2.31M
RNXT icon
32
RenovoRx
RNXT
$50.5M
$1.68M 0.29%
1,666,098
+1,066,098
+178% +$1.03M
PROF
33
Profound Medical
PROF
$252M
$1.65M 0.29%
254,753
– –
CUE icon
34
Cue Biopharma
CUE
$128M
$1.57M 0.27%
227,305
– –
CGEM icon
35
Cullinan Oncology
CGEM
$1.26B
$1.42M 0.25%
+100,000
New +$1.29M
POCI icon
36
Precision Optics
POCI
$45.4M
$1.19M 0.21%
270,925
+50,695
+23% +$232K
LLYVK icon
37
Liberty Live Group Series C
LLYVK
$9.8B
$1.17M 0.2%
13,802
– –
RTX icon
38
RTX Corp
RTX
$300B
$1.16M 0.2%
6,000
– –
PXLW icon
39
Pixelworks
PXLW
$42.3M
$1.09M 0.19%
201,015
– –
MODD icon
40
Modular Medical
MODD
$11.2M
$987K 0.17%
186,986
+91,667
+96% +$983K
QTI
41
QT Imaging Holdings
QTI
$41.4M
$978K 0.17%
+166,666
New +$991K
TLPH icon
42
Talphera
TLPH
$72.7M
$977K 0.17%
1,307,787
+426,621
+48% +$386K
OWLT icon
43
Owlet
OWLT
$169M
$884K 0.15%
172,000
-138,000
-45% -$1.46M
IPWR icon
44
Ideal Power
IPWR
$70M
$849K 0.15%
300,000
+167,000
+126% +$591K
FEAM icon
45
5E Advanced Materials
FEAM
$67.3M
$700K 0.12%
+500,000
New +$1.19M
MAIA icon
46
MAIA Biotechnology
MAIA
$83.9M
$700K 0.12%
+500,000
New +$922K
ICCC icon
47
ImmuCell
ICCC
$99.3M
$643K 0.11%
101,594
– –
SHAZ
48
SharonAI Holdings
SHAZ
$2.58B
$568K 0.1%
+25,000
New +$601K
LHX icon
49
L3Harris
LHX
$54.1B
$552K 0.1%
1,600
– –
LLYVA icon
50
Liberty Live Group Series A
LLYVA
$9.59B
$502K 0.09%
6,047
– –
1
2
3 4

Similar funds

NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
MCM
Maytus Capital Management New York $562M AUM 71.97% 1-Year Est. Return
FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return

Bleichroeder LP's Q1 2026 Portfolio in Review

As of Q1 2026, Bleichroeder LP held 86 positions worth $579M, up 1.8% from $568M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Bleichroeder LP deployed $40.5M of net new capital in Q1 2026, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was Envoy Medical: 6,250,000 shares worth $4.16M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 28% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Linde, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q1 2026 buy was Envoy Medical: 6,250,000 shares worth $4.16M.
  • Bleichroeder LP added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $23.8M increase.
  • Bleichroeder LP's biggest Q1 2026 reduction was Linde, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Structure Therapeutics in Q1 2026, selling an estimated $696K.
  • Bleichroeder LP's ten largest holdings make up 80% of its $579M portfolio in Q1 2026.
  • Bleichroeder LP opened 13 new positions and closed 5 in Q1 2026.
  • Bleichroeder LP's portfolio value rose 1.8% quarter-over-quarter to $579M.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.